Stocks and Investing Stocks and Investing
Fri, December 4, 2020
Thu, December 3, 2020

Konstantinos Aprilakis Initiated (SNDX) at Strong Buy and Held Target at $32 on, Dec 3rd, 2020


Published on 2024-10-27 14:55:38 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of Stifel, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $32 on, Dec 3rd, 2020.

Konstantinos has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, all agrees with Konstantinos's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebowitz of "Morgan Stanley" Maintained at Hold with Increased Target to $17 on, Wednesday, November 4th, 2020
Contributing Sources